DS-5565
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Pain Associated With Fibromyalgia
Conditions
Pain Associated With Fibromyalgia
Trial Timeline
Feb 4, 2015 → Apr 19, 2017
NCT ID
NCT02234583About DS-5565
DS-5565 is a phase 3 stage product being developed by Daiichi Sankyo for Pain Associated With Fibromyalgia. The current trial status is completed. This product is registered under clinical trial identifier NCT02234583. Target conditions include Pain Associated With Fibromyalgia.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02607280 | Phase 3 | Completed |
| NCT02234583 | Phase 3 | Completed |
Competing Products
20 competing products in Pain Associated With Fibromyalgia